Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, March 29 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate... Read More


Tripura: Animesh Debbarma slams Tipra Motha leadership, warns of split before TTAADC polls

India, March 29 -- Speculation partially came true after photos of Tipra Motha leader and Forest Minister Animesh Debbarma attending a meeting convened by the Bharatiya Janata Party (BJP) went viral o... Read More


Assam election 2026: Congress expels 15 members for six years over anti-party activities

India, March 29 -- The Assam Congress, acting ahead of the state Assembly elections, removed 15 party members from its ranks for six years on Sunday, March 29, citing serious breaches of party rules a... Read More


TAI urges Assam government to clarify land transfer rules for tea workers

India, March 29 -- TAI further demanded the release of pending subsidies under the Assam Tea Industries Special Incentive Scheme (ATISIS 2020), warning that delays could hurt the financial health of t... Read More


Centralized electronic system for asset and liability declarations to launch on March 31

Sri Lanka, March 29 -- The Commission to Investigate Allegations of Bribery or Corruption (CIABOC) has taken steps to open a centralized electronic system for asset and liability declarations to decla... Read More


Truck driver 'rams, kills' pump manager in Narail after not getting fuel

Dhaka, March 29 -- The manager of a petrol pump has allegedly been killed following an argument in Narail after a truck driver was unable to get fuel. Another worker at the pump has been seriously inj... Read More